Linked issuers
2
Insider Ownership Activity for Cam Gallagher
SEC Forms 3/4/5 positions, issuer links, and transaction evidence for this reporting owner.
Largest position
Opus Genetics, Inc.
Disclosed value
$17.14M
Transaction activity
Available
- Reporting-owner positions (Forms 3/4/5)
-
Forms 3/4/5 connect reporting owners to issuers, positions, and transactions disclosed to the SEC. They are filing-backed ownership signals, not a complete capitalization table.
Estimated position value
3/4/5$17.14MEstimated from parsed Forms 3/4/5 when filings include enough share and price data.
Source: Forms 3/4/5Confidence: Estimate depends on reported shares and pricesLinked issuers
3/4/52Distinct issuers connected to this reporting owner in parsed SEC filings.
Scope: Reporting-owner relationships, not all shareholdersLargest linked position
3/4/5$9.55M from parsed reporting-owner filings.
Source: Linked issuer filing trailLatest parsed filing
SEC22 Apr 2026Most recent reporting-owner filing date in the parsed SEC record.
Freshness: Most recent parsed reporting-owner filingHow to read Forms 3/4/5 positions
- Reported values are filing-backed estimates from parsed SEC Forms 3/4/5 when the filing includes enough share and price data.
- Use this as reporting-owner context, not as a full capitalization table or a public-float ownership breakdown.
- Reporting-owner location
- San Diego, CA
- Latest reporting-owner signature
-
/s/ Amy Rabourn, by Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
- Source filing history
-
Open source filing history
Source: SEC Forms 3/4/5Freshness: Reporting-owner filing trail
Ownership signals
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Follow Filing Activity
Follow Cam Gallagher and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Cam Gallagher
IRD
Forms 3/4/5
Opus Genetics, Inc.
- Relationship
- Director
- Holdings value
- $9,549,526
- Past year net change
- +$323,693
- Change %
- +3.5%
- Report period
- 20 Apr 2026
ZNTL
Forms 3/4/5
Zentalis Pharmaceuticals, Inc.
- Relationship
- President, Interim CFO, Director
- Holdings value
- $7,591,486
- Past year net change
- Change %
- Report period
- 31 May 2024
Recent insider transactions for Cam Gallagher
| Sym | Company | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.